Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting Held On 28.03.2023.
Outcome of Board meeting held on 28.03.2023.28-03-2023
28-03-2023
Concord Drugs Ltd - 538965 - Closure of Trading Window
Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015.28-03-2023
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting Held On 27.03.2023
Outcome of Board meeting held on 27.03.202327-03-2023
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Board Meeting To Be Held On 27.03.2023
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2023 ,inter alia, to consider and approve Intimation of board meeting to be held on 27.03.202316-03-2023
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Un-audited Financial Results for Quarter ended 31.12.202216-02-2023
Concord Drugs Ltd - 538965 - Statement Of Deviation / Variation In Utilization Of Funds Raised In Preferential Allotment
Statement of Deviation / Variation in utilization of funds raised in preferential allotment15-02-2023
Concord Drugs Ltd - 538965 - Appointment of Company Secretary and Compliance Officer
Appointment of Company Secretary and Compliance officer.14-02-2023
Concord Drugs Ltd - 538965 - Outcome Of Board Meeting Held On 14.02.2023.
Outcome of Board Meeting held on 14.02.2023.14-02-2023
Concord Drugs Ltd - 538965 - Board Meeting Intimation for To Consider And Approve Un-Audited Financial Results For The Quarter Ended 31.12.2022
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve To consider and approve un-audited financial results for the quarter ended 31.12.202202-02-2023
Concord Drugs Ltd - 538965 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under reg 74 (5)12-01-2023